Industry anticipates policy reversal for embryonic stem cells

11/10/2008 | Washington Post, The

Scientists and companies working on treatments based on stem cells are looking forward to President-elect Barack Obama's plan to repeal a directive restricting the use of federal funds for embryonic stem cell research. The move could boost interest and investment in firms such as Advanced Cell Technology, which has been struggling to obtain financing for research.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX